The levels of Vav3, a Rho GTPase guanine nucleotide exchange factor (GEF), are elevated in human prostate cancer specimens, and they increase during the progression of prostate cancer to androgen independence by enhancement of AR transcriptional activity [16,17]. This evidence concerns the gene AR and prostate cancer.